Literature DB >> 28530185

Effect of GNP functionalisation and multiple N-methylation of β-amyloid residue (32-37) on Gram-positive bacterium.

Nanjundaswamy Marishetty Hemmaragala1, Heidi Abrahamse2, Blassan P George2.   

Abstract

In the previous report, the authors showed the gold nanoparticle (GNP) functionalised multiple N-methylated fragments of the residue (32-37) of beta (β)-amyloid protein (1-42), CGGIGLMVG and CGGGGGIGLMVG toward disruption of β-amyloid (1-42), the predominant component of senile plaques. Herein the in vitro antimicrobial activities of both normal and multiple N-methylated sequences of CGGIGLMVG and CGGGGGIGLMVG were screened and it was found that all the eight sequences including four (non-functionalised with GNP) to possess activity against both Gram-positive [Staphylococcus aureus (ATCC 43300) and Enterococcus faecalis (ATCC 5129)] and Gram-negative [Escherichia coli (ATCC 35218), Pseudomonas aeruginosa (ATCC 27853) and Klebsiella pneumoniae (ATCC 700603)] bacteria. Among them, N-methylated sequences CGGIGLMVG and CGGGGGIGLMVG shown remarkable activity against Gram-positive bacteria.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28530185      PMCID: PMC8676080          DOI: 10.1049/iet-nbt.2016.0083

Source DB:  PubMed          Journal:  IET Nanobiotechnol        ISSN: 1751-8741            Impact factor:   1.847


  24 in total

Review 1.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

2.  Interaction of beta-amyloid interactions with peptide functionalized gold nanoparticles.

Authors:  Nanjundaswamy M Hemmaragala; Per I Arvidsson; Glenn E M Maguire; Hendrik G Kruger; Thavendran Govender
Journal:  J Nanosci Nanotechnol       Date:  2012-03

3.  N-methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles.

Authors:  Morteza Malakoutikhah; Roger Prades; Meritxell Teixidó; Ernest Giralt
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

Review 4.  Oral delivery of peptide drugs: barriers and developments.

Authors:  Josias H Hamman; Gill M Enslin; Awie F Kotzé
Journal:  BioDrugs       Date:  2005       Impact factor: 5.807

5.  Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.

Authors:  W L Cody; J X He; M D Reily; S J Haleen; D M Walker; E L Reyner; B H Stewart; A M Doherty
Journal:  J Med Chem       Date:  1997-07-04       Impact factor: 7.446

Review 6.  Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease.

Authors:  Christian Holscher
Journal:  Recent Pat CNS Drug Discov       Date:  2010-06

7.  Basics and recent advances in peptide and protein drug delivery.

Authors:  Benjamin J Bruno; Geoffrey D Miller; Carol S Lim
Journal:  Ther Deliv       Date:  2013-11

Review 8.  Silver and gold-catalyzed multicomponent reactions.

Authors:  Giorgio Abbiati; Elisabetta Rossi
Journal:  Beilstein J Org Chem       Date:  2014-02-26       Impact factor: 2.883

Review 9.  Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.

Authors:  Kelly C L Mulder; Loiane A Lima; Vivian J Miranda; Simoni C Dias; Octávio L Franco
Journal:  Front Microbiol       Date:  2013-10-31       Impact factor: 5.640

Review 10.  Chemical methods for peptide and protein production.

Authors:  Saranya Chandrudu; Pavla Simerska; Istvan Toth
Journal:  Molecules       Date:  2013-04-12       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.